This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Ranked Growth Stocks to Buy for March 20th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 20th
Why Is RenaissanceRe (RNR) Down 5.3% Since Last Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Grab These 5 High Earnings Yield Stocks for Solid Returns
by Zacks Equity Research
Importantly, earnings yield can be more useful than the traditional P/E ratio as the former facilitates comparisons of stocks with fixed- income securities.
Top Ranked Growth Stocks to Buy for February 25th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 25th
Will Increase in Premiums Aid Allstate (ALL) Q4 Earnings?
by Zacks Equity Research
Allstate's (ALL) Q4 results are likely to reflect increase in premium, partly offset by impairment and catastrophe charges.
Chubb (CB) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Chubb (CB) Q4 performance is likely to have benefited from premium growth in its Property and Casualty business, partly offset by loss in Agricultural business and catastrophes.
Prudential (PRU) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Prudential Financial's (PRU) Q4 performance is likely to have benefited from growth in asset-based businesses, solid international operations and pension risk transfer business.
The Zacks Analyst Blog Highlights: PotlatchDeltic, RenaissanceRe, Royal Gold, NGL Energy Partners and Silicon Motion Technology
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PotlatchDeltic, RenaissanceRe, Royal Gold, NGL Energy Partners and Silicon Motion Technology
5 Must-Buy Top Stocks Poised to Gain on Earnings Next Week
by Nalak Das
Fourth-quarter 2019 earnings results are improving gradually. However, overall earnings are still expected to dip.
P&C Insurance Industry Outlook Buoyant on Multiple Tailwinds
by Sapna Bagaria
Economic growth, solid capitalization, increased insurance prices, mergers and consolidation, and adoption of technology bode well for insurers.
4 Insurance Stocks Poised to Beat Earnings Estimates in Q4
by Sapna Bagaria
Rising insurance premium rates, solid capital position, changes to product portfolio and increased use of technology are likely to have driven earnings for insurers in Q4.
Travelers' (TRV) Earnings Beat Estimates in Q4, Surge Y/Y
by Zacks Equity Research
Travelers' (TRV) Q4 earnings top on the back of higher premiums and significantly lower catastrophe loss.
Reasons Why Investors Should Buy Everest Re Group (RE) Stock
by Zacks Equity Research
Everest Re Group (RE) remains poised for growth on higher investment income, solid capital position and financial flexibility.
Here's Why Chubb Limited (CB) Stock is an Attractive Bet
by Zacks Equity Research
Chubb Limited (CB) is poised to grow given its strong presence in global markets and efficient capital deployment.
MetLife Hits New 52-Week High: What's Driving the Rally?
by Sapna Bagaria
MetLife (MET) benefits from recent deals and strong operating performance.
The Zacks Analyst Blog Highlights: RenaissanceRe, MGIC Investment, Hallmark Financial Services and Trupanion
by Zacks Equity Research
The Zacks Analyst Blog Highlights: RenaissanceRe, MGIC Investment, Hallmark Financial Services and Trupanion
Amerisafe (AMSF) Rides on Underwriting Gains & Cost Control
by Zacks Equity Research
Underwriting profitability driven by improving combined ratio and cost-control efforts boost Amerisafe's (AMSF) margins.
4 Insurance Stocks for Your Investment Portfolio in 2020
by Zacks Equity Research
Rising insurance premium rates, solid capital position, changes to product portfolio and stable interest rate should drive insurance stocks in 2020.
RenaissanceRe Outshines in 2019: Will the Rally Continue?
by Zacks Equity Research
RenaissanceRe (RNR) holds enough potential to grow in 2020 on its growth initiatives and rising premiums.
ALL vs. RNR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ALL vs. RNR: Which Stock Is the Better Value Option?
Why Is RenaissanceRe (RNR) Up 3.1% Since Last Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RenaissanceRe Up 44.5% in a Year: Further Upside Left?
by Zacks Equity Research
RenaissanceRe's (RNR) segmental contribution is likely to boost its revenues, which in turn, might perk up its share price.
ALL vs. RNR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ALL vs. RNR: Which Stock Is the Better Value Option?
RenaissanceRe's (RNR) Q3 Earnings Miss Estimates, Tumble Y/Y
by Zacks Equity Research
RenaissanceRe's (RNR) third-quarter earnings suffer catastrophe events and high costs.
ALL or RNR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALL vs. RNR: Which Stock Is the Better Value Option?